Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy.

Laura BadinaBeatrice BelluzziSarah ContornoBenedetta BossiniElisa BenelliEgidio BarbiIrene Berti

Published in: Immunity, inflammation and disease (2021)

In this series, OML was effective in patients with severe CM allergy who had previously failed OIT, allowing milk intake without adverse reactions and improving the QoL.

Keyphrases

early onset
randomized controlled trial
atopic dermatitis
systematic review
drug induced
physical activity
emergency department
weight gain